| Page 2014 | Kisaco Research
 

Jo Sliman

Chief Medical Officer
Synthetic Biologics

From January 13, 2014 until January 17, 2017, Dr. Sliman served as the Company’s Senior Vice President-Clinical & Regulatory Affairs. Dr. Sliman has more than 18 years of experience in clinical and public health research, including 10 years directing clinical projects and product development, in therapeutic areas such as infectious diseases and vaccines. From September 2012 until January 2014, Dr.

Jo Sliman

Chief Medical Officer
Synthetic Biologics

Jo Sliman

Chief Medical Officer
Synthetic Biologics

From January 13, 2014 until January 17, 2017, Dr. Sliman served as the Company’s Senior Vice President-Clinical & Regulatory Affairs. Dr. Sliman has more than 18 years of experience in clinical and public health research, including 10 years directing clinical projects and product development, in therapeutic areas such as infectious diseases and vaccines. From September 2012 until January 2014, Dr. Sliman served as Senior Medical Director and Head of Patient Safety and Pharmacovigilance at Vanda Pharmaceuticals Inc., where he directed efforts for a New Drug Application for HETLIOZ (tasimelteon), which is indicated for the treatment of Non-24 Hour Disorder in totally blind adults. From December 2008 until August 2012, Dr. Sliman served as Medical Director in Vaccines and Infectious Diseases at MedImmune, Inc., where he was a member of successful Biologics Licensure Application teams. Prior to joining MedImmune, Inc., he served as Associate Medical Director at Dynport Vaccine Company, where he was the clinical director for seasonal and pandemic influenza vaccine trials as well as its Defense Vaccines development program (partnered with Department of Defense Joint Vaccines Acquisition Program).  During his service in the United States Navy, Dr. Sliman led the U. S. Pacific Fleet disease surveillance programs, including influenza surveillance, preparedness, and prevention, as well as communicable disease and injury surveillance and prevention and health policy development. Dr. Sliman earned an M.D. from the Uniformed Services University, a Master’s Degree in Public Health from the Johns Hopkins University School of Public Health, and a B.S. in Molecular and Cell Biology, with Honors in Biology, from Pennsylvania State University.

 

Professor Andreas Bäumler

UC Davis School of Medicine

Professor Andreas Bäumler

UC Davis School of Medicine

Professor Andreas Bäumler

UC Davis School of Medicine
 

Gregory Buck

Professor, Director, Center for the Study of Biological Complexity
VCU

Gregory Buck

Professor, Director, Center for the Study of Biological Complexity
VCU

Gregory Buck

Professor, Director, Center for the Study of Biological Complexity
VCU
 

Josie Ni

Division of Gastroenterology, Perelman School of Medicine
University of Pennsylvania

Josie was born in Taipei, Taiwan, and grew up in Chicago. She received her undergraduate education from University of California, Berkley, and attended Medical School at Northwestern University. Josie did her Residency at NYU Langone Medical Center in New York, where she was  selected as the curriculum Chief Resident, charged with creating a formal program curriculum.

Josie Ni

Division of Gastroenterology, Perelman School of Medicine
University of Pennsylvania

Josie Ni

Division of Gastroenterology, Perelman School of Medicine
University of Pennsylvania

Josie was born in Taipei, Taiwan, and grew up in Chicago. She received her undergraduate education from University of California, Berkley, and attended Medical School at Northwestern University. Josie did her Residency at NYU Langone Medical Center in New York, where she was  selected as the curriculum Chief Resident, charged with creating a formal program curriculum.

 

Susan Lynch

Director, Colitis and Crohn's Disease Microbiome Research Core
UCSF

Research in the Lynch laboratory addresses key areas of human microbiome research:

• Early-life microbiome assembly
• Community perturbation and reassembly
• Relationships between microbiome composition, function and chronic immune activation
• Development of rationally designed novel microbiome-based therapeutics
• The gut-airway axis

Susan Lynch

Director, Colitis and Crohn's Disease Microbiome Research Core
UCSF

Susan Lynch

Director, Colitis and Crohn's Disease Microbiome Research Core
UCSF

Research in the Lynch laboratory addresses key areas of human microbiome research:

• Early-life microbiome assembly
• Community perturbation and reassembly
• Relationships between microbiome composition, function and chronic immune activation
• Development of rationally designed novel microbiome-based therapeutics
• The gut-airway axis

 

Sarkis K. Mazmanian

Luis B. and Nelly Soux Professor of Microbiology; Investigator, Heritage Medical Research Institute. B.S.
University of California

Sarkis Mazmanian is a medical microbiologist. He has been employed at the California Institute of Technology since 2006, and is currently the Louis & Nelly Soux Professor of Microbiology in the Division of Biology and Biological Engineering. Before his current position, he was associated with the University of Chicago and Harvard Medical School. In 2012, Mazmanian was awarded a MacArthur Fellowship for his pioneering work on the human microbiome. Mazmanian's research investigates the symbiotic relationship between beneficial bacteria and their hosts.

Sarkis K. Mazmanian

Luis B. and Nelly Soux Professor of Microbiology; Investigator, Heritage Medical Research Institute. B.S.
University of California

Sarkis K. Mazmanian

Luis B. and Nelly Soux Professor of Microbiology; Investigator, Heritage Medical Research Institute. B.S.
University of California

Sarkis Mazmanian is a medical microbiologist. He has been employed at the California Institute of Technology since 2006, and is currently the Louis & Nelly Soux Professor of Microbiology in the Division of Biology and Biological Engineering. Before his current position, he was associated with the University of Chicago and Harvard Medical School. In 2012, Mazmanian was awarded a MacArthur Fellowship for his pioneering work on the human microbiome. Mazmanian's research investigates the symbiotic relationship between beneficial bacteria and their hosts. In seminal work, Mazmanian discovered the first microbial molecule that has direct beneficial effects on mammals.

 

Jim Weston

Vice President and Head of Regulatory Affairs
Seres Therapeutics

Jim Weston

Vice President and Head of Regulatory Affairs
Seres Therapeutics

Jim Weston

Vice President and Head of Regulatory Affairs
Seres Therapeutics
 

Janet Jansson

Division Director of Biological Sciences
Pacific Northwest National Laboratory

Janet Jansson is the Division Director of Biological Sciences at the Pacific Northwest National Laboratory (PNNL). She is also PNNL’s sector manager for the U.S. Department of Energy Office of Biological and Environmental Research’s Biological Systems Science Division. Before coming to PNNL (June 2014) she was a senior staff scientist at Lawrence Berkeley National Laboratory (2007-2014) and headed the Ecosystems Biology Program for the Earth Sciences Division at the Berkeley Lab.

Janet Jansson

Division Director of Biological Sciences
Pacific Northwest National Laboratory

Janet Jansson

Division Director of Biological Sciences
Pacific Northwest National Laboratory

Janet Jansson is the Division Director of Biological Sciences at the Pacific Northwest National Laboratory (PNNL). She is also PNNL’s sector manager for the U.S. Department of Energy Office of Biological and Environmental Research’s Biological Systems Science Division. Before coming to PNNL (June 2014) she was a senior staff scientist at Lawrence Berkeley National Laboratory (2007-2014) and headed the Ecosystems Biology Program for the Earth Sciences Division at the Berkeley Lab. She also held Adjunct Professor positions at UC Berkeley and the University of Copenhagen, Denmark, from 2012-2014.

 

Mary Regan

Associate Professor
University of Maryland School of Nursing

Mary Regan has a strong clinical background in perinatal nursing, with specific training and expertise in bio informatics. She trained as a certified nurse midwife in the United Kingdom and spent over 19 years working as a perinatal nurse specialist where she gained considerable expertise in pregnancy related health issues. She has been the PI on many State-funded grants and has received NIH funding for a grant focused on women’s decision making about birth (R21 HD059074-01A1) and the vaginal microbiota in preterm birth (R01NR014826-02).

Mary Regan

Associate Professor
University of Maryland School of Nursing

Mary Regan

Associate Professor
University of Maryland School of Nursing

Mary Regan has a strong clinical background in perinatal nursing, with specific training and expertise in bio informatics. She trained as a certified nurse midwife in the United Kingdom and spent over 19 years working as a perinatal nurse specialist where she gained considerable expertise in pregnancy related health issues. She has been the PI on many State-funded grants and has received NIH funding for a grant focused on women’s decision making about birth (R21 HD059074-01A1) and the vaginal microbiota in preterm birth (R01NR014826-02). The findings from the R21 have been presented internationally and multiple publications have disseminated the findings. The R01 is in its final year and to date over 200 women have been recruited from the birthing population in Baltimore and followed for six month through pregnancy and to the post part period. Dr. Regan works as an Associate Professor in the School of Nursing at the University of Maryland. She serves on the board of Improving Birth.

 

Rachel Webster PhD

Decision Resources

Rachel Webster PhD

Decision Resources

Rachel Webster PhD

Decision Resources